StockrabitBrowse analysts
Analyst questions

Gagan Thareja

ASK Investment Management
1Call
1Company
Read latest question
MANKIND

Mankind Pharma Limited

All company calls
Mankind Pharma Limited CC-Dec23.pdf
2 Feb 2024
Open call

  1. The first question is, can you quote the share of sales coming from DPC or NLEM?

    Read in transcript

  2. On the Dydrogesterone facility at Udaipur, can you give us some idea of what sort of scale up we can see from that in the coming year?

    Read in transcript

  3. Two questions related to that. One, I mean in terms of scale up of sales of Dydrogesterone, would there be a sharp ramp up next year ? And second, obviously currently the OPEX is under absorbed and therefore consequently next year would it mean that margins should benefit from the ramp up?

    Read in transcript
+4 more questions in this call